PURE RED CELL APLASIA INDUCED BY FK506
- 1 March 1996
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 61 (5), 831,832-2
- https://doi.org/10.1097/00007890-199603150-00026
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical responseBritish Journal of Haematology, 1991
- Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin.Proceedings of the National Academy of Sciences of the United States of America, 1990
- FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATIONThe Lancet, 1989